What CTT Pharmaceutical Holdings Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 16 | 20 |
| Sells | 0 | 0 |
| Total trades | 16 | 20 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 20 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Oct 26 | Open-market buy · P | +5,880 | $0.06 | +$335 | 9,442,536 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Oct 15 | Open-market buy · P | +2,000 | $0.06 | +$114 | 9,436,656 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Oct 06 | Open-market buy · P | +3,700 | $0.06 | +$204 | 9,433,656 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Sep 28 | Open-market buy · P | +3,400 | $0.06 | +$187 | 9,429,956 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Sep 22 | Open-market buy · P | +10,100 | $0.05 | +$455 | 9,424,556 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Sep 22 | Open-market buy · P | +10,100 | $0.05 | +$455 | 1,056,800 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Sep 16 | Open-market buy · P | +10,900 | $0.05 | +$523 | 9,414,456 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Sep 10 | Open-market buy · P | +3,500 | $0.05 | +$175 | 9,400,556 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Sep 04 | Open-market buy · P | +9,800 | $0.05 | +$479 | 9,397,056 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Sep 02 | Open-market buy · P | +3,000 | $0.05 | +$147 | 9,387,256 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Aug 31 | Open-market buy · P | +3,500 | $0.05 | +$172 | 9,384,256 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Aug 24 | Open-market buy · P | +2,100 | $0.06 | +$116 | 9,360,756 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Aug 20 | Open-market buy · P | +11,500 | $0.05 | +$518 | 9,378,656 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Aug 19 | Open-market buy · P | +10,000 | $0.06 | +$590 | 9,365,456 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Aug 14 | Open-market buy · P | +1,800 | $0.06 | +$112 | 9,355,456 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Aug 07 | Open-market buy · P | +7,700 | $0.07 | +$501 | 9,353,656 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Dec 17 | Open-market buy · P | +8,300 | $0.06 | +$457 | 7,845,956 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Nov 20 | Open-market buy · P | +62,900 | $0.04 | +$2.52K | 7,837,656 |
| Ctt Pharmaceutical HOLDINGS, Inc. | Director | Nov 20 | Open-market buy · P | +200,000 | $0.04 | +$8K | 3,734,003 |
| Ctt Pharmaceutical HOLDINGS, Inc. | CEO | Oct 31 | Open-market buy · P | +7,000 | $0.06 | +$420 | 7,774,756 |
Loading...